More about Narayana Hrudayalaya Limited
Fundamentals for Narayana Hrudayalaya Limited
Regulatory Filings for Narayana Hrudayalaya Limited
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
Fundamentals for Narayana Hrudayalaya Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Revenue projections:
Revenues for Narayana Hrudayalaya Limited are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 31.344313 |
| debtToEquity | 57.614000 |
| earningsGrowth | -0.343000 |
| revenueGrowth | 0.574000 |
| grossMargins | 0.417480 |
| operatingMargins | 0.113880 |
| trailingEps | 38.370000 |
| forwardEps | 56.415340 |
NH's forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting NH to generate stronger earnings compared to the previous financial year.
Price projections:
NH's stock price has regularly been near the lower end of projections, indicating that it may be struggling to attract investor interest. This pattern suggests a cautious sentiment surrounding the company's future performance.
Insider Transactions:
Recent trading of NH stock saw 1 sales, with market price at 1957.300048828125 per share.There were no sell transactions throughout the period under consideration.Narayana Hrudayalaya Limited's current price levels are seeing more buying activity than selling, which might indicate a bullish sentiment. Investors appear to be confident, interpreting the buying trend as a sign of positive expectations for the stock's future performance.
Recommendation changes over time:
Analysts' recent buy bias toward Narayana Hrudayalaya Limited suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see Narayana Hrudayalaya Limited as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy
The Hidden Engine of Global Growth: Why India Is Becoming Impossible to Overlook
₹10,000 Crore Deep-Tech Pivot: Why Fund of Funds 2.0 Will Redraw India's Startup Map